Using the form, filter the technologies based on your search criteria. The results are based on the combined criteria.
KU researchers have developed a drug target for the treatment of Huntington's disease.
Lonidimine derivates can be used to inhibit Hsp90 and, therefore, treat, prevent and/or inhibit abnormal cell growth with a favorable toxicity profile.
The millimeter resolution mouse force tracker (MRMFT) is a single device for collecting and quantifying the behaviors of laboratory mice.
The present invention is an entirely new chemotype of KOR weak partial agonists.
KU researchers have developed a biomimetic scaffold for tracheal tissue regeneration, using polycaprolactone (PCL) electrospun fibers.
The invention is a device capable of bridging remote brain areas through real time brain microstimulation to promote rapid functional recovery after brain injury.